JamesHFeusnerMD

Pediatric Hematology & Oncology • Oakland, CA

Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology

Director Oncology Childrens Hospital & Research Center Oakland. PI BATI NCORP. Prof Peds

Join to view full profile

Dr. Feusner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Feusner's full profile

Already have an account?

Office
747 52nd Street
Oakland, CA 94609
Phone+1 510-428-3372

Fax+1 510-601-3916
Is this information wrong?

Education & Training

University of WashingtonFellowship, Pediatric Hematology/Oncology, 1975 - 1978
University of WashingtonResidency, Pediatrics, 1973 - 1975
University of Southern California/LAC+USC Medical CenterInternship, Pediatrics, 1972 - 1973
University of Washington School of MedicineClass of 1972

Certifications & Licensure

CA State Medical License 1979 - 2025
FL State Medical License 2019 - 2021
WA State Medical License 1974 - 1986
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 3
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection Start of enrollment: 2006 Jun 01
Completed
Phase 3
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2007 Mar 15
Completed
Phase 1, Phase 2
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2007 Jul 01
Completed
Phase 3
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Start of enrollment: 2008 Mar 01
Completed
Phase 2
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
Active, not recruiting
Phase 3
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
Completed
Phase 2
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy Start of enrollment: 2008 Jun 15
Completed
Phase 3
Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2008 Apr 15
Completed
Phase 2
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer Start of enrollment: 2010 Apr 01
Completed
Phase 2
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Start of enrollment: 2010 Apr 01
Completed
Phase 2
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2010 Sep 01
Completed
Phase 1, Phase 2
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Vitamin D and Breast Cancer Biomarkers in Female Patients Start of enrollment: 2010 Oct 01
Completed
Phase 3
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy Start of enrollment: 2012 Feb 01
Completed
Phase 3
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01
Completed
Phase 2
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
Monica Davini, Caroline Hastings, James Feusner> ;Journal of Pediatric Hematology/oncology. 2024 Mar 27
3 citations
Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors In...
Angela D Trobaugh-Lotrario, Rudolf Maibach, Daniel C Aronson, Arun Rangaswami, Beate Häberle, Allison F O'Neill, Irene Schmid, Marc Ansari, Tomoro Hishiki, Sarangaraja...> ;Cancers. 2023 Jan 11
1 citations
Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance?
Kathryn L Laurie, Paul Lee, Alfred Rademaker, Todd A Alonzo, Yi-Cheng Wang, Bayard L Powell, Diana Wu, Richard Larson, Matthew Kutny, John Gregory, Nobuko Hijiya, Jame...> ;Pediatric Blood & Cancer. 2022 Jun 1
10 citations
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
Angela Trobaugh-Lotrario, Howard M Katzenstein, Sarangarajan Ranganathan, Dolores Lopez-Terrada, Mark D Krailo, Jin Piao, Nadia Chung, Jessica Randazzo, Marcio H Malog...> ;Journal of Clinical Oncology. 2022 Feb 10
29 citations
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAM...
Matthew A. Kutny, Todd A. Alonzo, Oussama Abla, Madhvi Rajpurkar, Robert B. Gerbing, Yi-Cheng Wang, Betsy A. Hirsch, Susana C. Raimondi, Samir B. Kahwash, Kristina K. ...> ;JAMA Oncology. 2021 Nov 11
1 citations
Utilization of Thiopurine Metabolites and Allopurinol in Pediatric Acute Lymphoblastic Leukemia: Consideration for an Algorithmic Approach.
Nichole Mosher, Joseph C. Torkildson, Carla Golden, Robert Raphael, Barbara Beach, Jennifer Michlitsch, James H. Feusner, Anurag K. Agrawal> ;Journal of Pediatric Hematology/oncology. 2021 Sep 6
1 citations
Zinc deficiency and its association with treatment-related toxicity in children with cancer
Jong Hee Chung, Neelam Phalke, Caroline Hastings, David W. Killilea, James H. Feusner, Ellen B. Fung> ;Pediatric Blood & Cancer. 2021 Jun 1
3 citations
Nelarabine in Pediatric and Young Adult T-Cell Acute Lymphoblastic Leukemia—Clearly Beneficial?
Anurag K. Agrawal, Jennifer Michlitsch, Carla Golden, Caroline Hastings, Robert Raphael, James H. Feusner> ;Journal of Clinical Oncology. 2021 Jan 14
11 citations
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance).
Matthew A. Kutny, Susan Geyer, Kristina Laumann, John Gregory, Cheryl L. Willman, Wendy Stock, Richard A. Larson, Bayard L. Powell, James H. Feusner> ;Pediatric Blood & Cancer. 2019 Mar 1
15 citations
Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
Madhvi Rajpurkar, Todd A. Alonzo, Yi-Cheng Wang, Robert B. Gerbing, Alan S. Gamis, James H. Feusner, John Gregory, Matthew A. Kutny> ;Journal of Pediatric Hematology/oncology. 2019 Jan 1
35 citations
Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening.
Angela D. Trobaugh-Lotrario, Dolores Lopez-Terrada, Peng Li, James H. Feusner> ;Pediatric Blood & Cancer. 2018 Aug 1
2 citations
Unifying the diagnosis of isolated central nervous system relapse in acute lymphoblastic leukaemia based on minimal residual disease testing.
Anurag K. Agrawal, Ana Aguilar, James H. Feusner> ;British Journal of Haematology. 2019 Mar 1
54 citations
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group ...
Matthew A. Kutny, Todd A. Alonzo, Robert B. Gerbing, Yi-Cheng Wang, Susana C. Raimondi, Betsy A. Hirsch, Cecilia Fu, Soheil Meshinchi, Alan S. Gamis, James H. Feusner,...> ;Journal of Clinical Oncology. 2017 Aug 2
28 citations
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy
Oussama Abla, Raul C. Ribeiro, Anna Maria Testi, Pau Montesinos, Ursula Creutzig, Lillian Sung, Giancarlo Di Giuseppe, Derek Stephens, James H. Feusner, Bayard L. Powe...> ;Annals of Hematology. 2017 Jun 8
33 citations
Pediatric liver transplantation for hepatoblastoma
Angela D. Trobaugh-Lotrario, Rebecka L. Meyers, Greg Tiao, James H. Feusner> ;Translational Gastroenterology and Hepatology. 2016 May 20
34 citations
Unresectable hepatoblastoma: current perspectives.
Angela D. Trobaugh-Lotrario, Rebecka L. Meyers, Allison F. O'Neill, James H. Feusner> ;Hepatic Medicine. 2017 Feb 1
10 citations
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel.
Oussama Abla, Matthew A. Kutny, Anna Maria Testi, James H. Feusner, Ursula Creutzig, John Gregory, Brenda Gibson, Guy Leverger, Raul C. Ribeiro, Owen P. Smith, Franco ...> ;British Journal of Haematology. 2016 Sep 21
7 citations
Cerebral Metastasis of Hepatoblastoma: A Review.
Parul Rai, James H. Feusner> ;Journal of Pediatric Hematology/oncology. 2016 May 1
12 citations
Outcomes of Patients With Relapsed Hepatoblastoma Enrolled on Children's Oncology Group (COG) Phase I and II Studies
Angela D. Trobaugh-Lotrario, Rebecka L. Meyers, James H. Feusner> ;Journal of Pediatric Hematology/oncology. 2016 Apr 1
16 citations
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria.
Catherine C. Coombs, Lisa M. DeAngelis, James H. Feusner, Jacob M. Rowe, Martin S. Tallman> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Mar 1
6 citations
Fever at Diagnosis of Pediatric Acute Lymphoblastic Leukemia: Are Antibiotics Really Necessary?
Monica Khurana, Brian Lee, James H. Feusner> ;Journal of Pediatric Hematology/oncology. 2015 Oct 1
20 citations
Global Characteristics of Childhood Acute Promyelocytic Leukemia
Luoping Zhang, A. Samad, Maria S. Pombo-de-Oliveira, Ghislaine Scelo, Martyn T. Smith, James H. Feusner, Joseph L. Wiemels, Catherine Metayer> ;Blood Reviews. 2015 Mar 1
21 citations
Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: A report from the Children's Oncology Group
Lucie M. Turcotte, Michael K. Georgieff, Julie A. Ross, James H. Feusner, Gail E. Tomlinson, Marcio H. Malogolowkin, Mark Krailo, Nicole Miller, Rachel K. Fonstad, Log...> ;Pediatric Blood & Cancer. 2014 Nov 1
2 citations
Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemia
Daniel N. Dang, Heather D. Morris, James H. Feusner, Prasad Koduru, Kathleen S. Wilson, Charles F. Timmons, Maryellen Cavalier, Hung S. Luu> ;Journal of Pediatric Hematology/oncology. 2014 Nov 1
32 citations
Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment?
Angela D. Trobaugh-Lotrario, Rajkumar Venkatramani, James H. Feusner> ;Journal of Pediatric Hematology/oncology. 2014 Jul 1
Join now to see all

Press Mentions

Board of UCSF Benioff Children’s Hospitals Showcases Strength of EnterpriseJuly 1st, 2016

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

UCSF Benioff Children's Hospital OaklandOakland, California
Alta Bates Summit Medical Center-Alta Bates CampusBerkeley, California
John Muir Medical Center, Walnut CreekWalnut Creek, California
Providence Queen of the Valley Medical CenterNapa, California
UCSF Medical CenterSan Francisco, California